The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis | Zendy

Cong Dai | Zendy; Jianrui Lv | Zendy; Kang Liu | Zendy; Xiaoming Lei | Zendy; Wei Li | Zendy; Gang Wu | Zendy; Xinghan Liu | Zendy; Yuxiao Zhu | Zendy; Qian Hao | Zendy; Zhijun Dai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis

Author(s) -

Cong Dai,

Jianrui Lv,

Kang Liu,

Xiaoming Lei,

Wei Li,

Gang Wu,

Xinghan Liu,

Yuxiao Zhu,

Qian Hao,

Zhijun Dai

Publication year - 2018

Publication title -

aging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.473

H-Index - 90

ISSN - 1945-4589

DOI - 10.18632/aging.101476

Subject(s) - medicine , odds ratio , meta analysis , colorectal cancer , genotype , genetic model , confidence interval , oncology , hazard ratio , single nucleotide polymorphism , heterozygote advantage , thyroid cancer , cancer , biology , genetics , gene

The role of rs4919510 polymorphism in microRNA-608 (miR-608) and cancer susceptibility and prognosis remain controversial and debatable. We conducted a meta-analysis of twenty-four eligible publications on the association of rs4919510 polymorphism with cancer risk and/or prognosis. Odds ratios, hazard ratios, and 95% confidence interval were used to investigate the association between this polymorphism and susceptibility, overall survival, and recurrence-free survival of cancer. Overall, eighteen case-control studies and nine cohort studies evaluated the susceptibility and prognostic value of rs4919510 polymorphism in cancer, respectively. Pooled analysis showed that rs4919510 polymorphism was not associated with cancer risk in all five genetic models. When stratifying by different cancer sites, rs4919510 polymorphism was detected to have a significant association with a decreased risk of colorectal cancer in homozygous model ( P = 0.006) and recessive model ( P = 0.001), subgroup analysis also emerged a weakened correlation between rs4919510 polymorphism and an increased risk of papillary thyroid cancer in heterozygote model ( P = 0.04). Furthermore, the prognosis of rs4919510 variant in cancer patients showed that rs4919510 GG genotype was significant association with poor recurrence-free survival in homozygous models ( P = 0.04). The meta-analysis suggested that the microRNA-608 rs4919510 polymorphism maybe associate with a significantly decreased risk for colorectal cancer. Further investigations on larger populations are required to evaluate and confirm this relationship.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research